<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">SUZUKI, HIDENORI</style></author><author><style face="normal" font="default" size="100%">TAMAKI, TSUNEO</style></author><author><style face="normal" font="default" size="100%">NISHIO, MASAMI</style></author><author><style face="normal" font="default" size="100%">BEPPU, SHINTARO</style></author><author><style face="normal" font="default" size="100%">MUKOYAMA, NOBUAKI</style></author><author><style face="normal" font="default" size="100%">HANAI, NOBUHIRO</style></author><author><style face="normal" font="default" size="100%">NISHIKAWA, DAISUKE</style></author><author><style face="normal" font="default" size="100%">KOIDE, YUSUKE</style></author><author><style face="normal" font="default" size="100%">HASEGAWA, YASUHISA</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Peak of Standardized Uptake Value in Oral Cancer Predicts Survival Adjusting for Pathological Stage</style></title><secondary-title><style face="normal" font="default" size="100%">In Vivo</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2018-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1193-1198</style></pages><doi><style  face="normal" font="default" size="100%">10.21873/invivo.11363</style></doi><volume><style face="normal" font="default" size="100%">32</style></volume><issue><style face="normal" font="default" size="100%">5</style></issue><abstract><style  face="normal" font="default" size="100%">Background/Aim: To predict survival outcomes of different patients with the same stage of disease is difficult. The possible correlation between 18F-fluorodeoxyglucose (18F-FDG) uptake parameters and survival outcomes was investigated in oral squamous cell carcinoma patients by multivariate analysis adjusted for the pathological stage according to the 8th edition of the tumor-node-metastasis (TNM) classification of the Union for International Cancer Contro. Patients and Methods: 18F-FDG-uptake parameters of 28 patients were assessed by positron emission tomography with computed tomography (PET/CT). Results: A peak of standardized uptake value of primary tumor (p-SUVpeak) of ≥14.1 was significantly correlated with shorter overall survival by univariate and multivariate analyses adjusted for the pathological TNM stage. A p-SUVpeak of ≥14.1 was significantly associated with shorter local recurrence-free survival and disease-free survival. Conclusion: A higher p-SUVpeak on pretreatment 18F-FDG-PET/CT is a prognostic parameter of identifying lower survival outcomes.</style></abstract></record></records></xml>